Ra Pharmaceuticals to Present at the Cantor Fitzgerald Global Healthcare...
Wednesday, September 20th 2017 at 11:12am UTC CAMBRIDGE, Mass.–(BUSINESS WIRE)– Ra Pharmaceuticals, Inc. (NASDAQ:RARX), a clinical stage biopharmaceutical company focusing on the development of...
View ArticlePfizer Announces Outcome of FDA Advisory Committee Meeting for SUTENT® in...
Tuesday, September 19th 2017 at 5:15pm UTC NEW YORK–(BUSINESS WIRE)– Pfizer Inc. (NYSE:PFE) today announced that the U.S. Food and Drug Administration’s (FDA) Oncologic Drug Advisory Committee (ODAC)...
View ArticlePuma Biotechnology to Present at Cantor Fitzgerald Healthcare Conference
Monday, September 18th 2017 at 8:20pm UTC LOS ANGELES–(BUSINESS WIRE)– Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that Alan H. Auerbach, Chairman, Chief Executive...
View ArticleHearst Invests in Moffitt Cancer Center Subsidiary M2Gen
Wednesday, September 20th 2017 at 10:00am UTC M2Gen Harnesses both Clinical and Genetic Data to Accelerate New Treatments and Cures NEW YORK & TAMPA, Fla.–(BUSINESS WIRE)– Hearst, a market leader...
View ArticleIgnyta to Present at Cantor Fitzgerald 2017 Global Healthcare Conference
Wednesday, September 20th 2017 at 11:00am UTC SAN DIEGO–(BUSINESS WIRE)– Ignyta, Inc. (Nasdaq: RXDX), a biotechnology company focused on precision medicine in oncology, announced today that Jacob...
View ArticleCORRECTING and REPLACING Synergy Pharmaceuticals to Present at Upcoming...
Thursday, September 21st 2017 at 11:54pm UTC NEW YORK–(BUSINESS WIRE)– In the release dated September 6, 2017, the presentation date and time for the Cantor Fitzgerald Global Healthcare Conference...
View ArticleAbbVie and Bristol-Myers Squibb Announce Clinical Research Collaboration to...
Friday, September 22nd 2017 at 10:59am UTC NORTH CHICAGO, Ill. & NEW YORK–(BUSINESS WIRE)– AbbVie (NYSE: ABBV) and Bristol-Myers Squibb Company (NYSE: BMY) today announced a clinical trial...
View ArticleSage Therapeutics to Participate in Leerink Investor Conference
Friday, September 22nd 2017 at 8:05pm UTC CAMBRIDGE, Mass.–(BUSINESS WIRE)– Sage Therapeutics (NASDAQ: SAGE), a clinical-stage biopharmaceutical company developing novel medicines to treat...
View ArticleEnzo Biochem Schedules Teleconference to Discuss Fourth Quarter 2017 Results...
Friday, September 22nd 2017 at 7:33pm UTC NEW YORK–(BUSINESS WIRE)– Enzo Biochem, Inc. (NYSE:ENZ) will hold a conference call to discuss fiscal 2017 fourth quarter results Thursday, September 28,...
View ArticleVerastem to Present at the Cantor Fitzgerald Global Healthcare Conference
Friday, September 22nd 2017 at 11:15am UTC BOSTON–(BUSINESS WIRE)– Verastem, Inc. (NASDAQ:VSTM), focused on discovering and developing drugs to treat cancer, today announced that the company will...
View Article